Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAFE: Colchicine for Prevention of Atrial Fibrillation After Cardiac Surgery
NCT06798714Phase 4Completed
- Sponsor
- Tomsk Cardiology Research Institute
- Start
- Jan 2025
- Primary completion
- Jul 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in Atrial fibrillation (AFib), sponsored by Tomsk Cardiology Research Institute. Started Jan 2025; status: completed.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06798714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06798714.